CAS 905105-89-7

Casein Kinase II Inhibitor VI, TMCB

CAS: 905105-89-7

Casein Kinase II Inhibitor VI, TMCB is a drug that inhibits Casein Kinase II (CKII), which is an enzyme that regulates the production of proteins. It has been shown to inhibit the replication of RNA and synthesis of protein in human cells. This drug binds to the active site of CKII, preventing it from phosphorylating other proteins. TMCB has been shown to have an inhibitory effect on cancer cell growth and may be used as an alternative treatment for bone-related diseases such as osteoporosis. TMCB also inhibits herpes simplex virus, a virus responsible for causing cold sores. The inhibition of viral replication by TMCB may be due to its ability to bind acrylonitrile, a nucleophile that inhibits viral DNA polymerase activity. Autologous stem cells are able to form new bone when injected into areas where bone loss has occurred due to tumor necrosis or trauma. The use of this drug

Formel: C₁₁H₉Br₄N₃O₂

Reinheit: Min. 95%

Molekulargewicht: 534.82 g/mol

Ref: 3D-FLB10589

TMCB

CAS: 905105-89-7

CK2 and ERK8 inhibitor

Formel: C₁₁H₉Br₄N₃O₂

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 534.82

Ref: TM-T23461